Company Roche Holding AG

ROG

CH0012032048

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 11:30:39 2024-12-06 am EST			5-day change	1st Jan Change
257.00 ^CHF	+0.27%		+0.59%	+5.11%

Dec. 05	Swiss Stocks Close Flat as Local Unemployment Rate Edges Higher	MT
Dec. 05	Roche: FDA accepts Columvi's review in lymphoma	CF

Business description: Roche Holding AG

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Number of employees: 103,605

Sales by Activity: Roche Holding AG

Fiscal Period: December	2019	2020	2021	2022	2023
Pharmaceuticals - Roche Pharmaceuticals	48.15B	44.33B	45.71B	46.35B	44.43B
Pharmaceuticals - Chugai	6.25B	6.94B	8.36B	9.27B	7.2B
Diagnostics	13.05B	13.87B	17.86B	17.82B	14.16B
Elimination	-3.7B	-4.8B	-6.08B	-7.02B	-5.35B

See all business segments

Geographical breakdown of sales: Roche Holding AG

Fiscal Period: December	2019	2020	2021	2022	2023
United States	31.16B	28.63B	28.06B	29.31B	28.35B
Rest of Europe	9.67B	9.78B	11.38B	10.33B	9.7B
Rest of Asia	8.72B	8.63B	9.76B	9.85B	8.89B
Japan	4.67B	4.25B	5.07B	6.45B	4.46B
Latin America	2.86B	2.39B	2.75B	2.87B	2.97B
Germany	3.08B	3.35B	4.32B	3.32B	2.89B
Africa, Australia and Oceania	1.36B	1.32B	1.48B	1.52B	1.21B
Switzerland	1.24B	1.1B	2.12B	1.67B	1.12B
Rest of North America	986M	883M	916M	1.1B	838M

See all geographic segments

Managers: Roche Holding AG

Director	Title	Age	Since
Thomas Schinecker CEO	Chief Executive Officer	49	2023-03-14
Alan Hippe DFI	Director of Finance/CFO	57	2011-06-05
Levi Garraway CTO	Chief Tech/Sci/R&D Officer	56	2022-12-31
Pascale Schmidt CMP	Compliance Officer	51	2019-12-31
Bruno Eschli IRC	Investor Relations Contact	-	2014-07-31

See ROCHE HOLDING AG governance

Members of the board: Roche Holding AG

Manager	Title	Age	Since
André Hoffmann BRD	Director/Board Member	66	1995-12-31
Severin Schwan CHM	Chairman	57	2023-03-14
Richard P. Lifton BRD	Director/Board Member	71	2015-03-02
Claudia Dyckerhoff BRD	Director/Board Member	57	2016-02-29
Anita Hauser BRD	Director/Board Member	55	2017-03-13
Joerg Duschmale BRD	Director/Board Member	40	2020-03-16
Patrick Frost BRD	Director/Board Member	56	2020-03-16
Jemilah Mahmood BRD	Director/Board Member	65	2022-02-28
Akiko Iwasaki BRD	Director/Board Member	54	2023-02-28
Ulf Mark Schneider BRD	Director/Board Member	59	2023-02-28

Composition of the Board of Directors

Shareholders: Roche Holding AG

Name	Equities	%	Valuation
MFS International (UK) Ltd. 0.6140 %	4,313,464	0.6140 %	1 336 M CHF
MFS International Singapore Pte Ltd. 0.2623 %	1,842,498	0.2623 %	571 M CHF
State Street Global Advisors Ltd. 0.2131 %	1,497,209	0.2131 %	464 M CHF
Credit Suisse AG 0.1678 %	1,178,810	0.1678 %	365 M CHF
Sjunde AP-fonden 0.1445 %	1,015,509	0.1445 %	315 M CHF

Name	Equities	%	Valuation
Aristotle Capital Management LLC 0.0425 %	2,390,734	0.0425 %	96 M CHF
Saratoga Research & Investment Management 0.0414 %	2,325,810	0.0414 %	93 M CHF
Pacer Advisors, Inc. 0.0214 %	1,204,412	0.0214 %	48 M CHF
Boston Common Asset Management LLC 0.005707 %	320,739	0.005707 %	13 M CHF
Old National Bank (Investment Management) 0.004714 %	264,956	0.004714 %	11 M CHF

Name	Equities	%	Valuation
Hoffmann Family 64.97 %	69,318,000	64.97 %	23 504 M CHF
Maja Oeri 7.584 %	8,091,900	7.584 %	2 744 M CHF
Severin Schwan 0.2294 %	244,786	0.2294 %	83 M CHF
zCapital AG 0.1064 %	113,500	0.1064 %	38 M CHF
State Street Global Advisors Ltd. 0.0632 %	67,455	0.0632 %	23 M CHF

List of ROCHE HOLDING AG shareholders

Holdings: Roche Holding AG

Name	Equities	%	Valuation
CHUGAI PHARMACEUTICAL CO., LTD 59.89%	1,005,670,000	59.89%	48,459,657,115 $
ENTRADA THERAPEUTICS, INC. 7.38%	2,744,120	7.38%	47,034,217 $
ALIGOS THERAPEUTICS, INC. 14.35%	441,038	14.35%	4,313,352 $

Company details: Roche Holding AG

Roche Holding AG

Grenzacherstrasse 124

4058, Basel

+41 61 688 11 11

http://www.roche.com

Group companies: Roche Holding AG

Name	Category and Sector
Roche Finance Europe BV	Finance/Rental/Leasing
Roche Financial Management Ltd.
Roche Catalyst Investments Ltd.
Roche Financial Investments Ltd.
Viewics India Pvt Ltd.

See all subsidiaries

Other Pharmaceuticals

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
ROCHE HOLDING AG	+0.27%	+0.59%	+2.82%	-30.08%	235B
ELI LILLY AND COMPANY	+0.13%	+3.94%	+40.30%	+235.61%	744B
NOVO NORDISK A/S	+1.88%	+3.72%	+15.77%	+121.70%	493B
JOHNSON & JOHNSON	-0.14%	-3.68%	-4.67%	-8.37%	359B
ABBVIE INC.	+0.01%	-3.68%	+20.36%	+45.19%	311B
MERCK & CO., INC.	-0.44%	+1.43%	-2.40%	+40.41%	261B
ASTRAZENECA PLC	+0.34%	+0.40%	+5.17%	+27.39%	211B
NOVARTIS AG	-0.63%	-3.71%	+5.80%	+20.34%	205B
AMGEN INC.	-0.64%	-3.64%	+1.20%	+30.55%	147B
PFIZER, INC.	+0.12%	-1.83%	-10.63%	-50.02%	146B
Average	+0.21%	-0.49%	+7.37%	+43.27%	311.16B
Weighted average by Cap.	+0.38%	+0.50%	+13.94%	+82.59%